Seattle Facilities

 

United States Manufacturing Capacity

With state of the art clinical and commercial manufacturing facilities in both the United States and Europe, CMC Biologics has the capacity and flexibility to meet each customer’s individual manufacturing needs. CMC Biologics manufacturing facilities are multi-process, engineered for unilateral flow, and segregated to produce multiple products at different stages of manufacturing in multiple parts of the facility. This increases the flexibility and number of manufacturing solutions available to meet clients’ rigorous manufacturing and quality needs. Right. On Time.

  • Seattle Facility
  • Seattle Facility
  • Seattle Facility
  • Seattle Facility
  • Seattle Facility
  • Seattle Facility
  • Seattle Facility
  • Seattle Facility
  • Seattle Facility

Seattle Facilities

CMC Biologics operates multiple cGMP manufacturing lines and a variety of scales in our Seattle, Washington cell culture facility. The uni-flow design allows for capacity and technological flexibility, including extensive adoption of single-use systems, while ensuring compliance with current ICH guidelines required for cGMP compliance. Whatever the challenge, CMC Biologics is your solution for clinical and commercial manufacturing.

Facility Equipment and Technology

cGMP STAINLESS STEEL MANUFACTURING

  • 2 x 3000L identical stainless steel production bioreactor lines
  • 2 x 750L identical seed bioreactors
  • Two dedicated cell expansion suites

cGMP SINGLE-USE MANUFACTURING

  • 2 x 500L single-use production bioreactors
  • 100L single-use production bioreactor

cGMP SINGLE-USE COMMERCIAL MANUFACTURING

  • Bioreactor 6Pack™ line — 6 x 2000L single-use production bioreactors
  • 1 x 2000L seed train